BridgeMD
New treatment option for Pneumococcal Infection
Official title A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
ClinicalTrials.gov ID: NCT07300267
What this study is testing
What is V118C (Stage 1)?
V118C (Stage 1) is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for pneumococcal infection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Researchers are looking for new vaccines to prevent pneumococcal disease, which is any infection in the lungs or other parts of the body that is caused by a type of bacteria called Streptococcus pneumoniae. V118C is a new vaccine designed to help prevent disease from Streptococcus pneumoniae bacteria.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 15. Healthy volunteers may be eligible.
You may be able to join if
- The main include but are not limited to the following: Stage 1:
- Is previously vaccinated with 3 routine infant doses of Pneumococcal 20-valent conjugate vaccine (PCV20)
- Is 12 through 15 months of age Stage 2: \- Is approximately 2 months of age Both Stages:
- Was born at full term (gestational age greater than or equal to 37 weeks)
You likely can't join if
- The main exclusion criteria include but are not limited to the following: Stage 1: \- Has received a PCV dose at 10 months of age and older Stage 2:
- Has received prior administration of any pneumococcal vaccine Both stages:
- Has a history of invasive pneumococcal disease (IPD)
- Has a known hypersensitivity to any component of V118C or PCV20 including diphtheria toxoid
The study team makes the final eligibility decision.
Where it's taking place
- Madera, California, United States
- Miami, Florida, United States
- Tampa, Florida, United States
- Topeka, Kansas, United States
- Louisville, Kentucky, United States
- Columbia, Maryland, United States
- St Louis, Missouri, United States
- East Syracuse, New York, United States
- Greenville, South Carolina, United States
- Spartanburg, South Carolina, United States
- Carrollton, Texas, United States
- Garland, Texas, United States
- League City, Texas, United States
- Charlottesville, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 months to 15 months. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madera, California, United States; Miami, Florida, United States; Tampa, Florida, United States; Topeka, Kansas, United States; Louisville, Kentucky, United States; Columbia, Maryland, United States and 8 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.